FENC Q4 2020 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$216M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$170,000

Gross Profit

$170,000100.0% margin

Operating Income

-$3M-1968.2% margin

Net Income

-$3M-1904.7% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$577,000

Balance Sheet

Total Assets

$31M

Total Liabilities

$2M

Stockholders' Equity

$29M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$170,000	$0	—
Gross Profit	$170,000	$0	—
Operating Income	-$3M	-$4M	+10.0%
Net Income	-$3M	-$4M	+11.9%